Posted by Michael Wonder on 29 Aug 2016
TGA publishes AusPAR for pirfenidone (Esbriet)
29 August 2016 - The TGA hs published an AusPAR for Roche's Esbriet.
The TGA approved pirfenidone on 5 February 2016 for the treatment of idiopathic pulmonary fibrosis.
